Výsledky vyhledávání - "William Sago"

Representing and extracting lung cancer study metadata: Study objective and study design

Autor: Mary Han, Alex A. T. Bui, Andrea Oh, Phillip A. Abarca, Denise R. Aberle, Jean Garcia-Gathright, Edward B. Garon, Brian R. Wolf, Marshall L. Spiegel, William Sago

Publikováno v: Computers in Biology and Medicine. 58:63-72

This paper describes the information retrieval step in Casama (Contextualized Semantic Maps), a project that summarizes and contextualizes current research papers on driver mutations in non-small cell lung cancer. Casama?s representation of lung canc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bafa2410ad9f6774c7cc1c0db61ce616
https://doi.org/10.1016/j.compbiomed.2015.01.004

Zobrazit plný text záznamu

Two Years of Positive Mycobacterial Cultures at a Veterans Affairs Medical Center: II. Laboratory Findings

Autor: Elizabeth Sansing, Joseph Kaminsky, William Sago, Eugene Pearlman

Publikováno v: American Journal of Clinical Pathology. 146

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b8d9ef478e6160f21f5c5f412d2f7b88
https://doi.org/10.1093/ajcp/aqw155.010

Zobrazit plný text záznamu

Two Years of Positive Mycobacterial Cultures at a Veterans Affairs Medical Center: I. Demographic and Clinical Features

Autor: William Sago, Eugene Pearlman, Sherry Griffin, Joseph Kaminsky

Publikováno v: American Journal of Clinical Pathology. 146

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9a713afee0d1e1b4d3203b3173da4016
https://doi.org/10.1093/ajcp/aqw155.009

Zobrazit plný text záznamu

1 A Rare Case of Fryns Syndrome With Concurrent Semilobar Holoprosencephaly

Autor: Glenn Murray, William Sago

Publikováno v: American Journal of Clinical Pathology. 149:S1-S1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8053f4ca035ebb7e23964c55f7bec038
https://doi.org/10.1093/ajcp/aqx114.000

Zobrazit plný text záznamu

Evaluating causes of screen failure (SF) in non-small cell lung cancer (NSCLC) clinical trials requiring specific biomarker (BioM) results for enrollment

Autor: Danielle J. Nameth, Phillip A. Abarca, Edward B. Garon, Olayinka Oshodi, Carmel Diamant, Jonathan W. Goldman, Brian R. Wolf, Steven R. Carrasco, Blanca A. Ledezma, Carlos R. Adame, John M. Horton, Deborah Jean Lee Wong, Melody A. Mendenhall, Darren D. Pan, Marshall L. Spiegel, William Sago, Sarah M. Rosales, Daria Gaut, Mary Han

Publikováno v: Journal of Clinical Oncology. 33:7517-7517

7517 Background: Trials for NSCLC have increasingly targeted specific molecular abnormalities. This approach has led to approval of multiple drugs based on results in specific BioM populations prio...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7fc670ae47ce15010e7e966c231069e3
https://doi.org/10.1200/jco.2015.33.15_suppl.7517

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání